Determination of the Enantiomeric Purity of Trelagliptin by Pre-Column Derivatization and Liquid Chromatography on a Chiral Stationary Phase

被引:0
作者
Qi Wang
Xiuli Chen
Cuiwei Zhang
Mengya Liao
Mingxing Hu
Shuo Lin
Yongmei Xie
Wenya Yin
Yiwen Zhang
机构
[1] West China Hospital,State Key Laboratory of Biotherapy and Cancer Center
[2] Sichuan University,Department of Nutrition, Food Safety and Toxicology
[3] and Collaborative Innovation Center for Biotherapy,Department of Pathology
[4] West China School of Public Health,undefined
[5] Sichuan University,undefined
[6] The Affiliated Hospital of Luzhou Medical College,undefined
[7] Chengdu University of Traditional Chinese Medicine,undefined
来源
Chromatographia | 2015年 / 78卷
关键词
Column liquid chromatography; Chiral separation; Enantiomeric purity; Trelagliptin; Pre-column derivatization;
D O I
暂无
中图分类号
学科分类号
摘要
A precise and sensitive LC method for determination of enantiomeric purity of trelagliptin has been developed and validated. Pre-column derivatization was performed before separation. Baseline separation with a resolution factor >2.5 was accomplished within 10 min by use of a Chiralpak AD column (250 × 4.6 mm; particle size 5 µm) and n-hexane–2-propanol (90:10 v/v) as mobile phase at a flow rate of 1 mL min−1. Eluted analytes were monitored by UV detection at 260 nm. The effects of mobile phase composition and temperature on enantiomeric selectivity and on resolution of enantiomers were thoroughly investigated. Calibration curves were plotted within the concentration range 0.005–2 mg mL−1 (n = 12), and recoveries between 98.23 and 101.34 % were obtained, with relative standard deviation (RSD) <1.39 %. LOD and LOQ for the trelagliptin derivative were 1.51 and 5.03 µg mL−1; those for its enantiomer were 1.49 and 4.94 µg mL−1, respectively. The method was evaluated and validated by analysis of bulk samples of trelagliptin of different enantiomeric purity. It was demonstrated that the method was accurate, robust, and sensitive, and enabled practical analysis of real samples.
引用
收藏
页码:1395 / 1400
页数:5
相关论文
共 75 条
[1]  
Hedrington MS(2014)undefined Expert Opin Investig Drugs 23 1703-1711
[2]  
Davis SN(2014)undefined Chem Biol Inter 4 137-162
[3]  
Kushwaha RN(2006)undefined Lancet 368 1696-1705
[4]  
Haq W(2014)undefined Lancet Diabet Endocrinol 2 125-132
[5]  
Katti SB(2015)undefined Lancet Diabet Endocrinol 3 191-197
[6]  
Drucker DJ(2014)undefined Curr Med Chem 21 1-33
[7]  
Nauck MA(2007)undefined Curr Top Med Chem 7 547-555
[8]  
Inagaki N(2014)undefined Diabetes Metab Res Rev 30 646-653
[9]  
Onouchi H(2014)undefined Diabetes Obes Metab 16 891-899
[10]  
Sano H(2003)undefined Curr Opin Investig Drugs 4 412-420